The Dutch respiratory devices market is expected to grow with a CAGR of 9.6% during the forecast period.
During the COVID-19 pandemic, the demand for major respiratory devices such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators increased due to the high number of COVID-19-infected patients in the country. With the increased severity of COVID-19 in the country, several companies increased their ventilator production to combat the pandemic. For instance, in April 2020, Medtronic ramped up the production of ventilators by more than 40%, increasing the capacity to make and supply the devices to hospitals globally. Also, in April 2020, the Philips Foundation partnered with Refugee Company and its feedstock supplier to provide a loan for two mask-making machines to alleviate the shortage of medical face masks in the Netherlands. This indicates the urgent need for respiratory devices like ventilators, oxygen concentrators, and nebulizers, especially for COVID-19 patients in the country. Moreover, with the released COVID-19 restrictions and resumed treatment and elective surgery procedures, the demand for respiratory devices is expected to increase over the forecast period.
Certain factors attributing to the market growth are the increasing prevalence of respiratory disorders and growing applications in home care settings.
In addition, the rising geriatric population, who are more prone to develop respiratory disorders due to their weak immunity, is also contributing to the market growth. For instance, according to the 2022 statistics published by the UNPF in the Netherlands, a large proportion of the living population was aged between 15 and 64, accounting for 64% in 2022. In addition, as per the same source, 21% of the population was aged 65 years and above in 2022.
The increasing burden of respiratory diseases such as asthma, lung cancer, chronic obstructive pulmonary disease (COPD), sleep apnea, and tuberculosis among the population is also expected to increase the market growth over the forecast period. For instance, as per GLOBOCAN 2020 factsheet, about 13,500 new lung cancer cases were reported in the Netherlands in 2020. Also, the increasing number of smokers in the country raises the risk of developing lung cancer and other respiratory problems, which, in turn, is expected to increase the demand for respiratory devices. For instance, as per the statistics published by Netherlands Expertise Center for Tobacco Control in June 2022, about 20.6% of adults aged 18 years and older in the Netherlands smoked in 2021. Thus, the rising prevalence of respiratory issues among the population is expected to increase the demand for ventilators and other respiratory devices, thereby propelling the market's growth.
Additionally, as per an article published in European Respiratory Journal in July 2021, it was found that the prevalence of chronic obstructive pulmonary disease (COPD) is anticipated to increase in Europe (including the Netherlands) due to rising risk factors like smoking and air pollution. Similarly, from an article published in PLOS One in November 2022, it was found that the frequency of COPD in patients with COVID-19 was the highest in the Netherlands at 17% in 2021. Thus, the expected increase in the number of people suffering from COPD in the country and the rising prevalence is expected to increase the demand for inhalers and nebulizers to deliver various COPD medications to patients, which, in turn, is anticipated to propel the demand for respiratory devices over the forecast period.
Furthermore, rising government initiatives are also contributing to the market's growth. For instance, in May 2021, the Netherlands shipped 449 ventilators, 100 oxygen concentrators, and other medical supplies to India to fight against the COVID-19 pandemic. This is anticipated to increase the company’s focus on accelerating the production of ventilators and oxygen concentrators, thereby propelling the market's growth.
Therefore, owing to the aforementioned factors, the market studied is expected to grow over the forecast period. However, the high cost of devices such as ventilators and respiratory humidifier are likely to impede market growth during the forecast period.
A ventilator is an equipment that delivers mechanical ventilation by moving breathable air into and out of the lungs to deliver breaths to a patient who is unable or insufficiently breathing. Modern ventilators are microprocessor-controlled computers. However, patients can also be ventilated using a simple, hand-operated bag valve mask. Ventilators are most employed in intensive care, home care, emergency medicine, and anesthesiology. In addition, ventilators are used in the treatment of various respiratory diseases, and the growing prevalence of these diseases is expected to boost the segment's growth.
In addition, the increased number of COVID-19 infections among the population also increased the demand for ventilators in healthcare settings across the world, which, in turn, impacted the growth of the segment. For instance, an article published in the Nature Public Health Emergency Collection in February 2022 stated that the male population in the country was at high risk of mortality during the first three months of the outbreak in the Netherlands. Also, as per another article published in PLOS One in October 2021, it has been observed that moderate and severe traumatic brain injury cases were common in the elderly population and are the primary cause of death in people with severe trauma injuries. Thus, the high burden of brain injuries is also expected to increase the demand for ventilators over the forecast period, propelling the market's growth.
Furthermore, the companies increased their ventilator production to treat patients with respiratory insufficiency during the COVID-19 pandemic. For instance, Royal Philips doubled the production of its hospital ventilators in May 2020 and achieved a four-fold increase by the third quarter of 2020. Also, in April 2020, Philips introduced a new Philips Respironics E30 ventilator as a readily available ventilation alternative during the COVID-19 crisis in situations. Thus, such initiatives taken by the companies are expected to have a positive impact on the segment's growth.
Thus, owing to the aforementioned factors, such as the high burden of coronavirus infection, increasing prevalence of traumatic brain injury, and increasing product launches, the segment studied is expected to grow significantly during the forecast period.
The number of patients suffering from tuberculosis has increased in the country, which is anticipated to raise the demand for respirators to protect against inhaled toxins, propelling the market's growth. For instance, according to the data published by ECDC, in March 2022, 680 people with tuberculosis (TB) were reported in the Netherlands in 2021 compared to 622 patients with TB in 2020. Thus, the high number of TB infections in patients is expected to increase the demand for surgical masks to prevent the inhalation and spread of airborne droplet nuclei, thereby boosting segment growth.
Additionally, different types of masks are used to prevent and treat respiratory diseases. For instance, venturi masks and nasal prongs masks are used to treat acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD).
Furthermore, the rising government initiatives to reduce the number of COVID-19 cases in the country are anticipated to fuel the segment's growth. For instance, in November 2021, the Dutch government reintroduced surgical masks to curb the spread of COVID-19 infection among the population in the Netherlands. This is expected to increase the demand for masks, boosting the segment's growth.
Therefore, owing to the factors such as rising tuberculosis cases and growing government initiatives in the country, the segment studied is expected to grow over the forecast period.
This product will be delivered within 2 business days.
During the COVID-19 pandemic, the demand for major respiratory devices such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators increased due to the high number of COVID-19-infected patients in the country. With the increased severity of COVID-19 in the country, several companies increased their ventilator production to combat the pandemic. For instance, in April 2020, Medtronic ramped up the production of ventilators by more than 40%, increasing the capacity to make and supply the devices to hospitals globally. Also, in April 2020, the Philips Foundation partnered with Refugee Company and its feedstock supplier to provide a loan for two mask-making machines to alleviate the shortage of medical face masks in the Netherlands. This indicates the urgent need for respiratory devices like ventilators, oxygen concentrators, and nebulizers, especially for COVID-19 patients in the country. Moreover, with the released COVID-19 restrictions and resumed treatment and elective surgery procedures, the demand for respiratory devices is expected to increase over the forecast period.
Certain factors attributing to the market growth are the increasing prevalence of respiratory disorders and growing applications in home care settings.
In addition, the rising geriatric population, who are more prone to develop respiratory disorders due to their weak immunity, is also contributing to the market growth. For instance, according to the 2022 statistics published by the UNPF in the Netherlands, a large proportion of the living population was aged between 15 and 64, accounting for 64% in 2022. In addition, as per the same source, 21% of the population was aged 65 years and above in 2022.
The increasing burden of respiratory diseases such as asthma, lung cancer, chronic obstructive pulmonary disease (COPD), sleep apnea, and tuberculosis among the population is also expected to increase the market growth over the forecast period. For instance, as per GLOBOCAN 2020 factsheet, about 13,500 new lung cancer cases were reported in the Netherlands in 2020. Also, the increasing number of smokers in the country raises the risk of developing lung cancer and other respiratory problems, which, in turn, is expected to increase the demand for respiratory devices. For instance, as per the statistics published by Netherlands Expertise Center for Tobacco Control in June 2022, about 20.6% of adults aged 18 years and older in the Netherlands smoked in 2021. Thus, the rising prevalence of respiratory issues among the population is expected to increase the demand for ventilators and other respiratory devices, thereby propelling the market's growth.
Additionally, as per an article published in European Respiratory Journal in July 2021, it was found that the prevalence of chronic obstructive pulmonary disease (COPD) is anticipated to increase in Europe (including the Netherlands) due to rising risk factors like smoking and air pollution. Similarly, from an article published in PLOS One in November 2022, it was found that the frequency of COPD in patients with COVID-19 was the highest in the Netherlands at 17% in 2021. Thus, the expected increase in the number of people suffering from COPD in the country and the rising prevalence is expected to increase the demand for inhalers and nebulizers to deliver various COPD medications to patients, which, in turn, is anticipated to propel the demand for respiratory devices over the forecast period.
Furthermore, rising government initiatives are also contributing to the market's growth. For instance, in May 2021, the Netherlands shipped 449 ventilators, 100 oxygen concentrators, and other medical supplies to India to fight against the COVID-19 pandemic. This is anticipated to increase the company’s focus on accelerating the production of ventilators and oxygen concentrators, thereby propelling the market's growth.
Therefore, owing to the aforementioned factors, the market studied is expected to grow over the forecast period. However, the high cost of devices such as ventilators and respiratory humidifier are likely to impede market growth during the forecast period.
Netherlands Respiratory Devices Market Trends
Ventilators Segment is Expected to Grow Over the Forecasted Period
The ventilator segment is expected to witness significant growth in the respiratory devices market during the forecast period, owing to the factors such as the rising prevalence of respiratory diseases, brain injuries, cardiac arrest, and strokes among the population.A ventilator is an equipment that delivers mechanical ventilation by moving breathable air into and out of the lungs to deliver breaths to a patient who is unable or insufficiently breathing. Modern ventilators are microprocessor-controlled computers. However, patients can also be ventilated using a simple, hand-operated bag valve mask. Ventilators are most employed in intensive care, home care, emergency medicine, and anesthesiology. In addition, ventilators are used in the treatment of various respiratory diseases, and the growing prevalence of these diseases is expected to boost the segment's growth.
In addition, the increased number of COVID-19 infections among the population also increased the demand for ventilators in healthcare settings across the world, which, in turn, impacted the growth of the segment. For instance, an article published in the Nature Public Health Emergency Collection in February 2022 stated that the male population in the country was at high risk of mortality during the first three months of the outbreak in the Netherlands. Also, as per another article published in PLOS One in October 2021, it has been observed that moderate and severe traumatic brain injury cases were common in the elderly population and are the primary cause of death in people with severe trauma injuries. Thus, the high burden of brain injuries is also expected to increase the demand for ventilators over the forecast period, propelling the market's growth.
Furthermore, the companies increased their ventilator production to treat patients with respiratory insufficiency during the COVID-19 pandemic. For instance, Royal Philips doubled the production of its hospital ventilators in May 2020 and achieved a four-fold increase by the third quarter of 2020. Also, in April 2020, Philips introduced a new Philips Respironics E30 ventilator as a readily available ventilation alternative during the COVID-19 crisis in situations. Thus, such initiatives taken by the companies are expected to have a positive impact on the segment's growth.
Thus, owing to the aforementioned factors, such as the high burden of coronavirus infection, increasing prevalence of traumatic brain injury, and increasing product launches, the segment studied is expected to grow significantly during the forecast period.
Masks Segment is Expected to Have Significant Market Share Over the Forecast Period
The masks segment is expected to witness significant growth in the Dutch respiratory devices market during the forecast period. The factors attributing to the segment's growth are the increasing COVID-19 and tuberculosis infections, rising demand for masks to prevent the spread of infection, and growing company activities.The number of patients suffering from tuberculosis has increased in the country, which is anticipated to raise the demand for respirators to protect against inhaled toxins, propelling the market's growth. For instance, according to the data published by ECDC, in March 2022, 680 people with tuberculosis (TB) were reported in the Netherlands in 2021 compared to 622 patients with TB in 2020. Thus, the high number of TB infections in patients is expected to increase the demand for surgical masks to prevent the inhalation and spread of airborne droplet nuclei, thereby boosting segment growth.
Additionally, different types of masks are used to prevent and treat respiratory diseases. For instance, venturi masks and nasal prongs masks are used to treat acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD).
Furthermore, the rising government initiatives to reduce the number of COVID-19 cases in the country are anticipated to fuel the segment's growth. For instance, in November 2021, the Dutch government reintroduced surgical masks to curb the spread of COVID-19 infection among the population in the Netherlands. This is expected to increase the demand for masks, boosting the segment's growth.
Therefore, owing to the factors such as rising tuberculosis cases and growing government initiatives in the country, the segment studied is expected to grow over the forecast period.
Netherlands Respiratory Devices Market Competitor Analysis
The Dutch respiratory devices market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the major players are DeVilbiss Healthcare LLC, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare, Getinge AB, and GlaxoSmithKline PLC.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- DeVilbiss Healthcare LLC
- Dragerwerk AG
- Fisher & Paykel Healthcare Ltd
- GE Healthcare
- Getinge AB
- GlaxoSmithKline PLC
- Invacare Corporation
- Koninklijke Philips NV
- Medtronic PLC
- DEMCON Macawi Medical Systems BV
